


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.30%
+3.49%
+5.19%
MLTX
MoonLake Immunotherapeuti
$17.68
Risk Analysis

Earnings are forecast to decrease
MLTX Price Performance
$15.67 (+12.83%)
$12.52 (+41.21%)
$8.43 (+109.73%)
$38.55 (-54.14%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
MLTX Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLTX Street Sentiment is bullish and have negative views on the near-term outlook
MLTX has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 24, 2026
Downgrade
Buy
Jan 09, 2026
Upgrade
Buy
BTIG
Nov 21, 2025
Reiterate
Buy
HC Wainwright & Co.
Sep 30, 2025
Reiterate
Buy
Needham
MRK
Merck Company
119.30
-2.58%
SNY
Sanofi
48.35
+1.60%
LLY
Eli Lilly and
1022.02
-0.72%
INSM
Insmed
150.00
+0.94%
IFRX
InflaRx N.V.
0.93
-0.25%
What is MLTX current stock price?
What are MLTX stock strengths?
What is MLTX Risk Level?
What is MLTX market cap and volume?
What is MLTX current Stock IQ?
Should I buy MLTX stock right now?
Is MLTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for MLTX?
What does a 'Strong Sell' rating mean for MLTX?
What factors influence MLTX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
MLTX
MoonLake Immunotherapeuti
Current Price
$17.68
Runners Also Watch
MRK
Merck Company
119.30
-2.58%
SNY
Sanofi
48.35
+1.60%
LLY
Eli Lilly and
1022.02
-0.72%
INSM
Insmed
150.00
+0.94%
IFRX
InflaRx N.V.
0.93
-0.25%

MLTX Price Performance
$15.67 (+12.83%)
$12.52 (+41.21%)
$8.43 (+109.73%)
$38.55 (-54.14%)
MLTX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
MLTX Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLTX Street Sentiment is bullish and have negative views on the near-term outlook
MLTX has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
MLTX Stock IQ
Stock Insights
Risk Analysis

Earnings are forecast to decrease
MLTX Latest Analysis
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal.
Tue Feb 24, 2026
MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain. ) shares are up during Monday’.s premarket session following the topline results from its Phase 2 clinical trial of sonelokimab in treating axial spondyloarthritis.Axial Spondyloarthritis is a chronic immune-mediated inflammatory disease mainly affecting the spine and sacroiliac joints often causing chronic back pain stiffness .In the Phase 2 S-OLARIS trial 81% of patients treated with sonelokimab achieved a clin
Mon Feb 23, 2026
MoonLake Reports Positive Data From Phase 2 Trial Of Sonelokimab In Axial Spondyloarthritis . (RTTNews) - MoonLake Immunotherapeutics (MLTX) on Sunday announced positive results from its phase 2 trial of Investigational drug Sonelokimab in patients with radiographic and non-radiographic axial spondyloarthritis sending shares up over 10% to $20 in overnight trading.
Mon Feb 23, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MLTX Stock trends
MLTX Stock performance
MLTX Stock analysis
MLTX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.